PD-L1 on the surface of tumor cells attenuates T cell-mediated cytotoxicity binding to PD-1 on the surface of activated T lymphocytes, which forms an immunosuppressive tumor microenvironment and promotes tumor cell proliferation and immune escape57. The gene discussed is PDCD1; the disease is neoplasm.